Journals / Turkish Journal of Gastroenterology / 2017 / Cilt: 28 - Sayı: 5

Is glycogenic acanthosis a predictor of insulin resistance and metabolic syndrome?

Pages
337–341
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ORs [95% CI] of WC, IR, and MetS for GA were 0.68 [0.17-2.62], 7.12 [1.89-26.72], and 4.11 [1.04-16.21], respectively.Conclusion: These findings showed that IR and MetS were significantly associated with the presence of GA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: To evaluate the incidence of insulin resistance and metabolic syndrome (MetS) in patients with glycogenic acanthosis (GA).Materials and Methods: Thirty patients with GA, detected upon endoscopy, and 30 age- and sex-matched control patients without GA were included in this case-control study.
📊
Key Findings & Data:Patients with GA were considered group 1 and control group was considered group 2.
💡
Conclusion & Impact:ORs [95% CI] of WC, IR, and MetS for GA were 0.68 [0.17-2.62], 7.12 [1.89-26.72], and 4.11 [1.04-16.21], respectively.Conclusion: These findings showed that IR and MetS were significantly associated with the presence of GA.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: To evaluate the incidence of insulin resistance and metabolic syndrome (MetS) in patients with glycogenic acanthosis (GA).Materials and Methods: Thirty patients with GA, detected upon endoscopy, and 30 age- and sex-matched control patients without GA were included in this case-control study. Patients with GA were considered group 1 and control group was considered group 2. Anthropometric measurements [height, weight, and waist circumference (WC)], biochemical parameters [fasting plasma glucose (FPG), triglyceride, high-density lipoprotein (HDL), and low-density lipoprotein (LDL)], and serum fasting insulin levels were evaluated. Insulin resistance (IR) was estimated by the homeostatic model assessment of IR. MetS was diagnosed using the criteria of the National Cholesterol Education Program Adult Treatment Panel III. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to evaluate associations with GA.Results: There were no differences in terms of FPG, triglyceride, HDL, and LDL between groups (p-values 0.118, 0.114, 0.192, 0.086, respectively). WC was significantly higher in group 1 than in group 2 (103.77 vs 97.03, p=0.032). The number of patients with IR and MetS were significantly higher in group 1 than in group 2 (53.3% vs 13.3%, p=0.003 and 53.3% vs 23.3%, p=0.034). ORs [95% CI] of WC, IR, and MetS for GA were 0.68 [0.17-2.62], 7.12 [1.89-26.72], and 4.11 [1.04-16.21], respectively.Conclusion: These findings showed that IR and MetS were significantly associated with the presence of GA.

🔖

Cite This Article

TAHTACI, M., BOLAT, A. D., YÜREKLİ, Ö. T., KÖSEOĞLU, H., BAŞARAN, M., SARI, S. Ö., ERSOY, O. (2017). Is glycogenic acanthosis a predictor of insulin resistance and metabolic syndrome?. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 5, 337–341. https://ajindex.com/articles/410720

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Rose D, Furth EE, Rubesin SE. Glycogenic acanthosis. AJR Am J Roentgenol 1995; 164: 96
  2. Vadva MD, Triadafilopoulos G. Glycogenic acanthosis of the esophagus and gastroesophageal reflux. J Clin Gastroenterol 1993; 17: 79-83
  3. Nazligül Y, Aslan M, Esen R, et al. Benign glycogenic acanthosis lesions of the esophagus. Turk J Gastroenterol 2012; 23: 199- 202
  4. Bender MD, Allison J, Cuartas F, Montgomery C. Glycogenic acanthosis of the esophagus: a form of benign epithelial hyperplasia. Gastroenterology 1973; 65: 373-80
  5. Lopes S, Figueiredo P, Amaro P, et al. Glycogenic acanthosis of the esophagus: an unusually endoscopic appearance. Rev Esp Enferm Dig 2010; 102: 341-2
  6. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
  7. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72
  8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9
  9. Grundy SM, Grundy SM, Cleeman JI, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52
  10. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20
  11. Ghahremani GG, Rushovich AM. Glycogenic acanthosis of the esophagus: radiographic and pathologic features. Gastrointest Radiol 1984; 9: 93-8
  12. Tsai SJ, Lin CC, Chang CW, et al. Benign esophageal lesions: endoscopic and pathologic features. World J Gastroenterol 2015; 21: 1091-8
  13. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS. Glycogen and its metabolism: some new developments and old themes. Biochem J 2012; 441: 763-87
  14. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. C